TY - JOUR
T1 - International neurocognitive normative study
T2 - neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271
AU - For The Aids Clinical Trials Group
AU - Robertson, K.
AU - Jiang, H.
AU - Evans, S. R.
AU - Marra, C. M.
AU - Berzins, B.
AU - Hakim, J.
AU - Sacktor, N.
AU - Silva, M. Tulius
AU - Campbell, T. B.
AU - Nair, A.
AU - Schouten, J.
AU - With the 5271 study team, the 5271 study team
AU - Kumwenda, J.
AU - Supparatpinyo, K.
AU - Tripathy, S.
AU - Kumarasamy, N.
AU - la Rosa, A.
AU - Montano, S.
AU - Mwafongo, A.
AU - Firnhaber, C.
AU - Sanne, I.
AU - Naini, L.
AU - Amod, F.
AU - Walawander, A.
N1 - Funding Information:
The project described was supported by Award Number U01AI068636 from the National Institute of Allergy and Infectious Diseases and supported by the National Institute of Mental Health (NIMH) and National Institute of Dental and Craniofacial Research (NIDCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. This work was supported by the National Institute of Mental Health and the AIDS Clinical Trials Group (ACTG) funded by The National Institute of Allergy and Infectious Diseases (NIAID) Award Number U01AI068636 and Statistical and Data Analysis Center (SDAC) Grant Number AI-068634. Portions of this work were previously presented as WEPEB327 at the 8th International AIDS Conference, July 19–22, 2015, Vancouver, BC, CAN.
Funding Information:
Thomas Campbell, M.D., grant support from NIAID ACTU # AI069450.
Funding Information:
Dianne Rausch, Ph.D., and Pim Brouwers, Ph.D., Center for Mental Health Research on AIDS, National Institute of Mental Health. Thomas Campbell, M.D., grant support from NIAID ACTU # AI069450. Deise Vieira, M.D., and Marcus Tulius T Silva, M.D.?PhD-IPEC-FIOCRUZ (Site 12101) Rio de Janeiro, Brazil, CTU Grant # AI69476 Umesh Lalloo, M.D., F.R.C.P., and Rosie Mngqibisa, MB ChB, Durban, South Africa, Adult HIV CRS (Site 11201) CTU Grant # 5U01AI069426-03 Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., and Jabin Sharma-YRGCARE Medical Centre Chennai, India (Site 11701), CTU Grant # AI069432 Mitch Matoga MBBS, Mina Hosseinipour, M.D., University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi (Site 12001), CTU Grant # AI069518 Mauleen Waison and Rachel Mahachi-Parirenyatwa CRS (Site 30313), Harare, Zimbabwe, CTU Grant # BRS-ACURE-Q-08-00173-TOOI-OOO Cynthia Firnhaber, M.D. Sharla Faesen and Daphne S. Radebe, B.A.?Wits HIV Clinical Research Site (Helen Joseph Hosp) (Site 11101) Johannesburg, South Africa, CTU Grant# AI069463; BRS-ACURE-Q-07-00143 T006 Thira Sirisanthana, M.D. and Daralak Tavornprasit?Research Institute for Health Sciences-Chiang Mai University, Thailand (Site 11501), CTU Grant # AI069399; AACTG.27.5199.06 Anjali A. Joglekar, M.B.B.S. and Srikanth Prasad Tripathy, M.D., M.B.B.S.-NARI Pune, India CRS (Site 11601), CTU Grant # 5U01AI069417-03 Manisha V. Ghate, M.B.B.S., D.C.H. and Madhura Nene, M.B.B.S.?NARI-NIV Clinic, Pune, India (Site 11603), CTU Grant # 5U01AI069417-03 Dr. Raman Gnagakhedkar and Usha Katti, M.B.B.S.-Dr. Kotnis Dispensary, NARI, Pune, India (Site 11602), CTU Grant # 5U01AI069417-03 Ben Kalonga and Henry Chamba?Blantyre College of Medicine, Malawi-Johns Hopkins Project (Site 30301) CTU Grant # U01A1069518 Carlos Mosquera, M.D., and Rosa Infante, M.D.?INMENSA-Lince CRS Lima, Peru (Site 11302), CTU Grant # 5U01 AI069438-03; BRS-ACURE-Q-07-00141-T001-001 Jorge Sanchez, MD, MPH, and Juan Carlos Hurtado, M.D.?Asociaci?n Civil Impacta Salud y Educaci?n (Site 11301) Lima, Peru, CTU Grant # AI069438; BRS-ACURE-Q-08-00007-T-002 Dr. Scott R Evans and Hongyu Jiang were funded in part by the Statistical and Data Management Center of the Adult AIDS Clinical Trials Group grant 1 U01 068634. Jeffrey Schouten, MD CTU Grant# UM1 AI069481-08. The project described was supported by Award Number U01AI068636 from the National Institute of Allergy and Infectious Diseases and supported by the National Institute of Mental Health (NIMH) and National Institute of Dental and Craniofacial Research (NIDCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. This work was supported by the National Institute of Mental Health and the AIDS Clinical Trials Group (ACTG) funded by The National Institute of Allergy and Infectious Diseases (NIAID) Award Number U01AI068636 and Statistical and Data Analysis Center (SDAC) Grant Number AI-068634. Portions of this work were previously presented as WEPEB327 at the 8th International AIDS Conference, July 19?22, 2015, Vancouver, BC, CAN.
Funding Information:
Dr. Scott R Evans and Hongyu Jiang were funded in part by the Statistical and Data Management Center of the Adult AIDS Clinical Trials Group grant 1 U01 068634.
Publisher Copyright:
© 2016, Journal of NeuroVirology, Inc.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Infrastructure for conducting neurological research in resource-limited settings (RLS) is limited. The lack of neurological and neuropsychological (NP) assessment and normative data needed for clinical interpretation impedes research and clinical care. Here, we report on ACTG 5271, which provided neurological training of clinical site personnel and collected neurocognitive normative comparison data in diverse settings. At ten sites in seven RLS countries, we provided training for NP assessments. We collected normative comparison data on HIV− participants from Brazil (n = 240), India (n = 480), Malawi (n = 481), Peru (n = 239), South Africa (480), Thailand (n = 240), and Zimbabwe (n = 240). Participants had a negative HIV test within 30 days before standardized NP exams were administered at baseline and 770 at 6 months. Participants were enrolled in eight strata, gender (female and male), education (<10 and ≥10 years), and age (<35 and ≥35 years). Of 2400 enrolled, 770 completed the 6-month follow-up. As expected, significant between-country differences were evident in all the neurocognitive test scores (p < 0.0001). There was variation between the age, gender, and education strata on the neurocognitive tests. Age and education were important variables for all tests; older participants had poorer performance, and those with higher education had better performance. Women had better performance on verbal learning/memory and speed of processing tests, while men performed better on motor tests. This study provides the necessary neurocognitive normative data needed to build infrastructure for future neurological and neurocognitive studies in diverse RLS. These normative data are a much-needed resource for both clinicians and researchers.
AB - Infrastructure for conducting neurological research in resource-limited settings (RLS) is limited. The lack of neurological and neuropsychological (NP) assessment and normative data needed for clinical interpretation impedes research and clinical care. Here, we report on ACTG 5271, which provided neurological training of clinical site personnel and collected neurocognitive normative comparison data in diverse settings. At ten sites in seven RLS countries, we provided training for NP assessments. We collected normative comparison data on HIV− participants from Brazil (n = 240), India (n = 480), Malawi (n = 481), Peru (n = 239), South Africa (480), Thailand (n = 240), and Zimbabwe (n = 240). Participants had a negative HIV test within 30 days before standardized NP exams were administered at baseline and 770 at 6 months. Participants were enrolled in eight strata, gender (female and male), education (<10 and ≥10 years), and age (<35 and ≥35 years). Of 2400 enrolled, 770 completed the 6-month follow-up. As expected, significant between-country differences were evident in all the neurocognitive test scores (p < 0.0001). There was variation between the age, gender, and education strata on the neurocognitive tests. Age and education were important variables for all tests; older participants had poorer performance, and those with higher education had better performance. Women had better performance on verbal learning/memory and speed of processing tests, while men performed better on motor tests. This study provides the necessary neurocognitive normative data needed to build infrastructure for future neurological and neurocognitive studies in diverse RLS. These normative data are a much-needed resource for both clinicians and researchers.
KW - Cognitive impairment
KW - Neurocognitive assessment
KW - Neuropsychological functioning
KW - Normative comparison data
KW - Resource limited
UR - http://www.scopus.com/inward/record.url?scp=84953228926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84953228926&partnerID=8YFLogxK
U2 - 10.1007/s13365-015-0415-2
DO - 10.1007/s13365-015-0415-2
M3 - Article
C2 - 26733457
AN - SCOPUS:84953228926
SN - 1355-0284
VL - 22
SP - 472
EP - 478
JO - Journal of neurovirology
JF - Journal of neurovirology
IS - 4
ER -